Search
for
Sort by
Research 61–90 of 1000+
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Reactions to Drugs
- Cutaneous drug reactions
- Alopecia and drugs
- Cytostatics and immunosuppressive drugs
- Techniques for the discovery and evaluation of drugs against alopecia
- Drug Reactions Affecting Hair: Diagnosis
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- An Update on Drug-Induced Pigmentation
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- The PDGF/PDGFR pathway as a drug target
- In silico investigation of possible multi-target drugs against Glutamate S-transferase and prolyl tRNA synthetase in Onchocerca volvulus
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Hair Loss Pattern due to Chemotherapy-Induced Anagen Effluvium: A Cross-Sectional Observation
- Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- INHIBITION OF KERATINIZING STRUCTURES BY SYSTEMIC DRUGS
- Drug Induced Alopecia
- Microneedle-Based Approaches for Skin Disease Treatment
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications